Using a suppressive subtractive hybridization system, we identified CSIG (cellular senescence-inhibited gene protein; RSL1D1) that was abundant in young human diploid fibroblast cells but declined upon replicative senescence. Overexpression or knockdown of CSIG did not influence p21
Replicative senescence is defined as a state of proliferative arrest accompanying the replicative exhaustion of cultured human fibroblast cells (16) . The stable state of proliferation arrest limits the proliferation of damaged cells and may act as a natural barrier to cancer progression. Some genes linked to senescence in vitro also influence organismal life span in vivo, raising the possibility that replicative senescence underlies organismal aging (5, 8, 22, 31) . After a finite number of population doublings, human diploid fibroblasts exhibit senescent features (6) such as growth inhibition, cell cycle arrest (16) , enlarged and flat morphology (3), elevated senescence-associated ␤-galactosidase (SA-␤-gal) activity (10) , and accumulation of senescence-associated heterochromatin foci (26, 30) . Although viable and metabolically active, senescent cells remain permanently insensitive to mitogenic signals (7) .
Over the years, the molecular mechanisms that regulate the expression of genes whose levels are altered in senescent cells relative to those in young cells have been extensively studied. It is well accepted that decreased levels of cell cycle regulatory proteins such as cyclin A, CAK, Cdc2, E2F-1, E2F-2, and PCNA, as well as increased abundance of cyclin-dependent kinase (CDK) inhibitors, including p16
INK4a and p21 Cip1 , contribute to the growth inhibition of senescent cells (36, (38) (39) . In addition, the activities of Rb and p53 tumor suppressors are constitutively elevated in senescent cells and promote cell senescence (13, 17, 26) . In recent years, however, emerging evidence revealed that the tumor suppressor phosphatase and tensin homolog PTEN and its downstream effector p27 Kip1 are also critical for replicative senescence, although the upstream regulatory events remain largely unknown (1, 4, 34) . PTEN, a lipid phosphatase, is the central negative regulator of the phosphatidylinositol-3-kinase (PI3K) signal transduction cascade. PI3K catalyzes the conversion of phosphatidylinositol 4,5-phosphate (PIP2) to phosphatidylinositol 3,4,5-phosphate (PIP3) and activates AKT kinase and other downstream effectors (12) . PTEN dephosphorylates PIP3 at the plasma membrane, thereby inhibiting PI3K-mediated signals for cell growth, proliferation, and survival (32). Despite its regulatory function on the PI3K/AKT pathway, recent studies strongly suggest that a phosphatase-independent mechanism is important for the biological functions of PTEN in the nucleus (2) . By inhibiting ubiquitin-dependent proteasome turnover, PTEN elevates the p27
Kip1 level and induces G 1 arrest (23) . In addition, PTEN was also found to interact with and regulate p53 expression (14, 18) . Therefore, PTEN may act as a common regulator of both p53 and p27 Kip1 , which in turn, lead to cell cycle arrest and induce cell senescence.
Using a suppressive subtractive hybridization (15), we have identified and cloned a cellular senescence-inhibited gene (encoding CSIG; GenBank accession no. AY154473) (http://www .ncbi.nim.nih.gov). CSIG is abundantly expressed in young fibroblasts, but its expression declines during cellular senescence. CSIG is a ribosomal L1 domain-containing protein and therefore was also named as RSL1D1 in the Human Genome Organization (HUGO) Nomenclature Committee database. A BLAST search of the human genome database revealed that the human CSIG gene localizes on chromosome 16p13, spans 5,137 bp, and is composed of nine exons which encode 490 amino acid residues. According to informatics analysis (available at http://www.expasy .org), CSIG is evolutionarily conserved, and the human CSIG protein contains part of the ribosomal L1p/L10e consensus se-quence (residues 30 to 260) in the N terminus and a long lysinerich domain (residues 280 to 485) in the C terminus, suggesting that it may participate in ribosome biosynthesis or act as a transcriptional cofactor. As a differentially expressed gene involved in replicative senescence, the CSIG gene level is higher in young fibroblasts, while it is lower in senescent cells (15) . However, whether CSIG is an active regulator of replicative senescence remains to be addressed. In this study, we have investigated the role of CSIG in senescence and its underlying mechanisms using the human 2BS fibroblast model of replicative senescence. We demonstrate that CSIG potently regulates p27
Kip1 levels and the progression of cell senescence by regulating the translational level of PTEN.
MATERIALS AND METHODS
Cell culture, FACS analysis, cell proliferation, and SA-␤-gal activity. Earlypassage (young; ϳ28 population doublings [pdl]), middle-passage (middle-aged; ϳ45 pdl), and late-passage (senescent; ϳ58 pdl) human diploid 2BS fibroblasts (National Institute of Biological Products, Beijing, China), human glioblastoma U87MG cells (Chinese Academy of Medical Science, Beijing, China), human embryonic kidney HEK 293 cells, and HeLa cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen), supplemented with 10% fetal bovine serum, 100 units/ml penicillin, and 100 g/ml streptomycin, at 37°C in 5% CO 2 . Fluorescence-activated cell sorting (FACS) analysis, cell proliferation assessment, and SA-␤-gal staining were performed as described previously (11, 38) .
Construction of pIRES-CSIG and pSilencer-CSIG and transfection. For the construction of the vector expressing CSIG, the full-length CSIG cDNA was amplified by PCR and inserted into the EcoRI site in the pIRES neo2 vector (Clontech). For the construction of pSilencer-CSIG, oligonucleotides corresponding to small interfering RNA (siRNA) targeting the CSIG coding region (AGAAGGAACAGACGCCAGA) and a control (Ctrl) siRNA (AAGTGTAG TAGATCACCAGGC) were inserted into the BamHI and HindIII sites in the pSilencer 2.1-U6 neo vector (Ambion) to generate vectors expressing CSIG and Ctrl siRNAs by following the manufacturer's instructions.
To establish lines stably expressing CSIG or CSIG siRNA, early-passage (ϳ28 pdl) 2BS cells were transfected with either the pIRES-CSIG and pSilencer-CSIG constructs or the respective Ctrl vectors by the Lipofectamine 2000 reagent (Invitrogen) by following the manufacturer's instructions, selected by the G418 reagent (300 g/ml; Invitrogen) for 2 to 4 weeks, and maintained in medium supplemented with 50 g/ml G418.
To transiently silence CSIG, siRNA targeting CSIG (CSIG siRNA; AGAAG GAACAGACGCCAGA) and PTEN (PTEN siRNA; GUUAGCAGAAACAA AAGGAG) as well as a Ctrl siRNA (AAGTGTAGTAGATCACCAGGC) were transfected at concentrations indicated by the Oligofectamine reagent (Invitrogen) by following the manufacturer's recommendations. Cells were collected 48 to 72 h after transfection for further analysis.
Construction of pGEX-GST-CSIG, protein purification, and development of CSIG polyclonal antibody. For the construction of the pGEX-GST-CSIG vector expressing a glutathione S-transferase (GST)-CSIG fusion protein, the CSIG cDNA sequence corresponding to amino acid residues 320 to 365 was amplified by PCR using primers 5Ј-CGGGATCCGATGTGGCACCTGAAAGTG-3Ј and 5Ј-CCGCTCGAGTTAGATTTCGTCTTCGGATTCATTT-3Ј and cloned into the pGEX-4T-2 vector (Amersham-Pharmacia Biotech) at BamHI and XhoI sites. The pGEX-GST-CSIG vector was transformed into Escherichia coli BL21. Expression of GST-CSIG was induced by isopropyl-1-thio-␤-D-galactopyranoside (IPTG) and purified with glutathione-conjugated Sepharose beads (Pharmacia) by following the manufacturer's instructions.
To develop polyclonal antisera recognizing CSIG, purified GST-CSIG recombinant protein was emulsified in complete Freund's adjuvant as soluble antigen and injected into two rabbits. The animals were reinjected at 3-week intervals with the same dose of antigen in incomplete Freund's adjuvant, and the sera were collected 2 weeks after the second reinjection.
Immunofluorescence. To determine the subcellular localization of endogenous CSIG, 2BS and HeLa cells were fixed with cold methanol for 5 min at room temperature, washed with phosphate-buffered saline (PBS) twice for 5 min, permeabilized with 0.5% Triton X in 100 in PBS for 15 min, and blocked with 0.5% bovine serum albumin in PBS for 1 h. Immunofluorescence assay was carried out by incubating cells with antisera recognizing CSIG at room temperature for 2 h and then rinsing and incubating them with fluorescein isothiocyanate-conjugated secondary antibody for 1 h. The nucleoli were immunostained with antinucleolin antibody (sc-8031; Santa Cruz) and subsequent tetramethyl rhodamine isothiocyanate-conjugated secondary antibody. Signals were visualized by fluorescence confocal microscopy. DAPI (4Ј,6-diamidino-2-phenylindole) was used to visualize nuclei.
Northern and Western blot analysis. For Northern blot analysis, total RNA was isolated using an RNeasy mini kit (Qiagen) by following the manufacturer's protocol. Northern blot analysis was performed as previously described (15) Preparation of polysomal fractions. A total of 50 million cells were incubated for 15 min with 100 mg/ml cycloheximide, and total lysates (500 l) were layered onto a cushion of 30% sucrose in ice-cold buffer containing 20 mM HEPES (pH 7.4), 50 mM potassium acetate, 5 mM magnesium acetate, 1 mM dithiothreitol, 1 unit of RNasin per l, 1 g of leupeptin per ml, 1 g of aprotinin per ml, and 0.5 mM phenylmethylsulfonyl fluoride. After centrifugation (Beckman SW40; 100,000 ϫ g for 2 h, 4°C), the supernatant was collected as a nonpolysomal fraction; the pellet was resuspended in ice-cold buffer A (10 mM HEPES [pH 7.9], 10 mM KCl, 1.5 mM MgCl 2 ) containing 0.3 M NaCl, incubated on ice for 1 h, and centrifuged at 10,000 ϫ g for 15 min at 4°C; and the resulting supernatant (polysomal extract) was collected for Western blot analysis.
Analysis of nascent protein. 7 .5], 250 mM NaCl, 5 mM EDTA, 0.5% Nonidet P-40), immunoprecipitated material was resolved by 12% SDS-PAGE, transferred onto polyvinylidene difluoride membranes, and visualized by using a PhosphorImager (Molecular Dynamics).
RNA-protein binding assays. cDNA was used as a template for PCR amplification of different PTEN untranslated regions (UTR) and coding regions (CR). All forward primers contained the T7 promoter sequence 5Ј-CCAAGCTTCTA ATACGACTCACTATAGGGAGA-3Ј (T7). To prepare the PTEN 5Ј UTR (positions 114 to 983), primers (T7)GGGCGGTGATGTGGCGGGACTCTT and CTGCTGGTGGCGGGGCTTCTTCTG were used. To prepare the PTEN CR (positions 1032 to 1095), primers (T7)GGAGATATCAAGAGGATGGA TTCG and ATGCTGATCTTCATCAAAAG were used. To prepare the 3Ј UTR-1 (positions 2206 to 3269), 3Ј UTR-2 (positions 3244 to 4327), and 3Ј UTR-3 (positions 4280 to 5090) fragments, primers (T7)TTGATGAAGATCA GCATA and CATCCACAGCAGGTATTA, (T7)TTCAATCATAATACCT GCTG and TATGAAAGACAAGGTGGC, and (T7)ATTCTAACACCTCA CCAT and AATCAGTTTTAAGTGGAGT were used, respectively. For biotin pulldown assays, PCR-amplified DNA was used as a template to transcribe biotinylated RNA by using T7 RNA polymerase in the presence of biotin-UTP and was purified as described previously (38) . Six micrograms of biotinylated transcripts were incubated with 120 g of total cell lysates for 30 min at room temperature. Complexes were isolated with paramagnetic streptavidin-conjugated Dynabeads (Dynal, Oslo, Norway), and pulldown material was analyzed by Western blotting.
To assess the association of endogenous CSIG with endogenous PTEN mRNA, immunoprecipitation (IP) of endogenous CSIG-mRNA complexes was performed as described previously (38) . HEK 293 cells were collected, and total cell lysates (100 g) were used for IP for 4 h at room temperature in the presence of excess (3 g) IP antibody (either rabbit polyclonal anti-CSIG antibody or IgG). RNA in IP material was used in reverse transcription (RT)-PCRs to detect the PTEN mRNA by using primers 5Ј-CCGTTCCACCCTTTTGACC-3Ј and 5Ј-TCGGGGGAGCACTATGAA-3Ј and the following amplification conditions: 30 s at 94°C, 30 s at 56°C, and 30 s at 72°C, for 30 cycles. PCR products were visualized by ethidium bromide staining of 1% agarose gels.
Reporter gene and competition assays. 
RESULTS
Expression of CSIG during replicative senescence and its subcellular localization. According to bioinformatic analysis, the CSIG protein contains a ribosomal L1 domain at the N terminus and a lysine-rich region in the C terminus and is predicted to localize in the nucleus or nucleolus (Fig. 1A) . We began our studies with the analysis of the distribution of CSIG in various human tissues by Northern blot analysis. As shown in Fig. 1B , CSIG was expressed at high intensities in the heart, skeletal muscle, and placenta. To confirm the subcellular localization of CSIG, the intracellular localization of human CSIG in both 2BS and HeLa cells was tested by immunofluorescence assays; the signal of CSIG was compared with the staining of nucleolin (a marker for nucleolus localization) and DAPI. The results shown in Fig. 1C suggest that human CSIG is predominantly localized in the nucleolus.
Given our previous findings by suppressive subtractive hybridization that CSIG expression was significantly reduced during replicative senescence (15), we examined the expression of CSIG in early-passage (young; ϳ28 pdl), middle-passage (middle-aged; ϳ45 pdl), and late-passage (senescent; ϳ58 pdl) human diploid 2BS fibroblasts by Western blot analysis. As shown in Fig. 1D , a CSIG protein band of about 55 kDa was observed. In agreement with our previous observations (15) , the expression of CSIG was high in young cells but decreased significantly during replicative senescence (ϳ2.5-fold decrease in middleaged cells, ϳ6.6-fold decrease in senescent cells), this agedependent reduction suggesting that CSIG may be implicated in the process of cellular senescence. 
CSIG suppresses PTEN and p27
Kip1 in replicative senescence. Given that CSIG was abundant in young human fibroblasts and reduced in senescent cells, we next tested the expression of several key mediators of replicative senescence (4, 11) , including PTEN and the CDK inhibitors p16
INK4a , p21 Cip1 , and p27 Kip1 , in 2BS lines with either elevated ( Fig. 2A ) or reduced (Fig. 2B ) levels of CSIG. Western blot analyses showed that the expression levels of p16
INK4a and p21 Cip1 were not affected by CSIG abundance. However, p27
Kip1 and PTEN protein levels were greatly decreased (ϳ4-fold for PTEN and ϳ7-fold for p27 Kip1 ) in cells with CSIG overexpression (Fig.  2A) . In contrast, their levels were markedly increased (ϳ5.4-fold for PTEN and ϳ6.1-fold for p27 Kip1 ) after CSIG knockdown. These results suggest that CSIG functions, at least in part, by suppressing PTEN and p27
Kip1 expression.
PTEN is required for the effect of CSIG on p27
Kip1 expression and cell cycle progression. It has been reported that PTEN regulates p27
Kip1 expression by inhibiting its proteasome degradation (23) . Therefore, we set out to investigate whether CSIG directly regulates p27
Kip1 expression levels or its effect is mediated by PTEN. To this end, human glioblastoma U87MG cells (U87) were utilized. U87 cells do not express detectable levels of PTEN but express levels of p27
Kip1 similar to those of HEK 293 and 2BS cells (Fig. 3A) . CSIG was overexpressed in U87 cells by transient transfection with pIRES-CSIG, or knocked down by transfection of siRNA targeting CSIG, as described in Materials and Methods. Parallel transfections using an enhanced green fluorescent protein-expressing vector revealed that over 90% of cells were transfected under our experimental conditions (data not shown). As shown in Fig. 3B , transfection of pIRES-CSIG in U87 cells resulted in an ϳ7-fold increase in CSIG expression relative to the CSIG levels in empty-vector-transfected cells (Fig. 3B, left  panel) . Conversely, transfection of CSIG siRNA led to an ϳ85% (ϳ6.7-fold) reduction in CSIG levels (Fig. 3B, right  panel) , compared with transfection of Ctrl siRNA. However, neither overexpression (Fig. 3B, left panel) nor silencing (Fig.  3B, right panel) of CSIG in U87 cells could remarkably alter the expression of p27 Kip1 , suggesting an essential role of PTEN in CSIG-dependent expression of p27 Kip1 . To further test the function of PTEN as a key mediator, we knocked down PTEN by transient transfection with its siRNA in HEK 293 cells, which express a level of PTEN similar to that expressed in 2BS cells (Fig. 3A) . Knockdown of PTEN in HEK 293 cells greatly diminished the effect of either overexpression (Fig. 3C, left  panel, lanes 3 and 4) or knockdown (Fig. 3C, right panel, lanes  3 and 4) of CSIG on p27
Kip1 expression. As a Ctrl, both PTEN and p27
Kip1 levels are affected by CSIG in HEK 293 cells transfected with Ctrl siRNA, consistent with our observations in 2BS cells ( Fig. 2A and B) . As shown in Fig. 3C , overexpression of CSIG (Fig. 3C, left 
Kip1 level by about 10-fold relative to Ctrls (empty-vector transfection), while silencing CSIG (Fig. 3C, right panel, lanes 1 and 2) by an siRNA approach led to an ϳ3-fold increase of PTEN and an ϳ5-fold increase of p27 Kip1 . As expected, silencing of CSIG in HEK 293 cells led to increased G 0 /G 1 and reduced S compartments (Fig. 3D) . However, in U87 or HEK 293 cells transfected with PTEN siRNA, silencing of CSIG had no significant effect on cell cycle distribution ( Fig. 3D and E) . These findings support the notion that CSIG directly regulates PTEN expression, which in turn regulates p27
Kip1 and cell cycle progression, and that this regulation likely occurs broadly, not limited to human fibroblasts.
CSIG regulates PTEN in translational levels. Next, we extended our study to the mechanism for how CSIG regulates PTEN expression. We first tested if the regulation is at the transcriptional level. HEK 293 cells were transiently transfected either with a pIRES-CSIG vector expressing CSIG to elevate CSIG level or with siRNA targeting CSIG (20 and 50 nM) to silence CSIG expression, as described in Fig. 3C . Two days after the transfection, mRNA levels of PTEN in transfected HEK 293 cells were tested. To our surprise, neither overexpression nor silencing of CSIG significantly affected the mRNA levels of PTEN (Fig. 4C and D) although the PTEN protein level was decreased by 10-fold in CSIG overexpression (Fig. 4A ) and increased in CSIG silenced cells (ϳ4-fold for 20 nM siRNA and ϳ10-fold for 50 nM siRNA) (Fig. 4B) at the translational level. In agreement with this view, although both PTEN and p27 Kip1 protein levels in senescent 2BS cells (ϳ58 pdl) were much higher (both exhibited a Ͼ20-fold increase) than those in young cells (ϳ28 pdl) (Fig. 4F, left  panel) , PTEN mRNA levels detected by Northern blot analysis stayed unchanged in the process of cellular senescence (Fig.  4F, right panel) . Taken together, our observations suggest that the passage-dependent elevation of PTEN levels in senescent cells is basically a result of translational regulation, and the reduction of CSIG during cell aging contributes to the agedependent elevation of PTEN translation.
CSIG associates with the 5 UTR of the PTEN mRNA and modulates its translation. Because CSIG localized in the nucleolus (Fig. 1C) and regulates specifically PTEN translation (Fig. 4) , we further asked if CSIG could interact with PTEN mRNA or PTEN translation complex. First, IP assays against CSIG polyclonal antibody under conditions that preserved endogenous protein-RNA complexes were performed, followed by RT-PCR amplification of the IP materials using sequencespecific primers. As shown, the PTEN mRNA was predominantly bound to CSIG, as a significant amount of PTEN PCR product was amplified from anti-CSIG IP reactions (Fig. 5B) . By contrast, IP assays using IgG showed undetectable signals, a Ctrl PCR product corresponding to the housekeeping GADPH mRNA serving to monitor background mRNA binding to IP material showed only weak background mRNA binding, and the analysis of GAPDH served to verify that the interaction between CSIG and PTEN mRNA was specific and the sample input was even. Further demonstration of the existence of the CSIG-PTEN mRNA complex was obtained through pulldown assays using biotinylated transcripts of PTEN 5Ј UTR, CR, and 3Ј UTR (3Ј UTR-1, 3Ј UTR-2, and 3Ј UTR-3). As shown in Fig. 5C , by Western blotting of CSIG in the pulldown materials, PTEN 5Ј UTR and CR (but not 3Ј UTR) were targets of CSIG. As a Ctrl, RNA binding protein HuR was found to interact with PTEN 3Ј UTR-1 and 3Ј UTR-2, but not with 5Ј UTR and CR. Because of the role of CSIG on PTEN translation, we isolated the polysomal fraction from HEK 293 cell lysates and studied the presence of CSIG in it. As shown in Fig. 5D , similar to HuR, which was proved to be a polysomal component (24) , CSIG was also present in the polysomal fraction. Together, these results showed that CSIG was capable of interacting with PTEN mRNA and that they colocalized within the polysomal compartment of the cell.
To address if PTEN 5Ј UTR or CR contains the CSIG response elements, luciferase reporter constructs expressing chimeric mRNAs, including PTEN 5Ј UTR-luciferase (pGL3-5Ј UTR), luciferase-PTEN CR (pGL3-CR), or luciferase-PTEN 3Ј UTR-2 (pGL3-3Ј UTR-2), were transiently transfected into either CSIG-silenced or Ctrl HEK 293 cells, followed by reporter gene assays. As shown in Fig. 5E , after CSIG silencing, luciferase activities of pGL3 (empty vector), pGL3-CR, and pGL-3Ј UTR-2 did not show a big difference compared with that of Ctrl cells, although protein-RNA binding assays showed that CSIG also bound to PTEN coding region (Fig. 5C ). By contrast, pGL3-5Ј UTR, expressing a chimeric mRNA encoding PTEN 5Ј UTR and luciferase, exhibited an ϳ2.5-fold increase in luciferase activity in CSIG-silenced cells compared with what was seen in Ctrl cells (Fig. 5E ). To confirm the specificity of the PTEN 5Ј UTR reporter activity and to identify CSIG response elements in the 5Ј UTR of PTEN, Fig. 5F (left panel) , as a result of competitive interaction with endogenous CSIG, expression of the PTEN 5Ј UTR fragment A increased the luciferase activity of pGL3-5Ј UTR in a dose-dependent (0, 2, 4, or 6 g/ml) manner. Further study revealed that expressions of fragments A, B, and C, but not D, elevated the luciferase activity of pGL3-5Ј UTR to a similar extent (ϳ1.65-fold, ϳ1.7-fold, and ϳ1.85-fold, respectively) compared with that observed in empty-vector-cotransfected cells (Fig. 5F, right panel) . These results suggest that the luciferase activity of pGL3-5Ј UTR is specific and that the CSIG response element may localize between nucleotide positions 700 and 830 in the PTEN 5Ј UTR.
CSIG is a regulator of cell proliferation and replicative senescence. Since CSIG repressed the PTEN/p27
Kip1 pathway, we further investigated if the regulation of PTEN/p27
Kip1 by CSIG had an impact on cellular senescence. To this end, CSIG expression in 2BS cells was either elevated by stable transfection with pIRES-CSIG or reduced by stable transfection with pSilencer-CSIG plasmids (see Materials and Methods). Expression of CSIG was monitored by Western blot analysis. As depicted in Fig. 6A , CSIG expression was about 5.5-fold higher in pIRES-CSIG-transfected cells (Fig. 6A, left panel) , but about 90% (10-fold) (Fig. 6A, right panel) lower in pSilencer-CSIG-transfected cells, than that seen in the Ctrl cells (transfected with empty vectors). These alterations were specific for CSIG since ␤-actin levels remained unchanged. Importantly, these interventions to either elevate or reduce CSIG expression levels influenced cell growth and the process of cellular senescence. As shown in Fig. 6 , cells overexpressing CSIG exhibited markedly elevated proliferation rates, showed increased S and reduced G 1 compartments, and displayed a feature of young cells (lower SA-␤-gal activity) compared with the empty-vector-transfected cells (Fig. 6B, C, VOL. 28, 2008 CSIG INFLUENCES SENESCENCE-ASSOCIATED PTEN EXPRESSIONactivity) (Fig. 6B , C, and D, right panels). These findings suggest that CSIG potentially regulates cell proliferation and replicative senescence in 2BS cells by suppressing PTEN translation. PTEN is required for CSIG's role in regulating replicative senescence. We next addressed whether PTEN is required for CSIG to regulate cellular senescence. For this purpose, 2BS cells were stably transfected with vectors expressing Ctrl siRNA or CSIG siRNA and cotransfected with vectors expressing either Ctrl siRNA plus PTEN siRNA or CSIG siRNA plus PTEN siRNA. Expression of CSIG, PTEN, and p27
Kip1 was monitored by Western blot analysis. As shown in Fig. 7A , consistent with our results from 2BS and HEK 293 cells (Fig. 2B and 3C) , transfection with vectors expressing PTEN siRNA led to an ϳ70 to 80% reduction of PTEN and a near loss of p27 Kip1 expression; by contrast, knockdown of CSIG increased p27
Kip1 by ϳ3.3-fold in Binding of CSIG to PTEN mRNA and influence of PTEN 5Ј UTR on the expression of a chimeric luciferase reporter construct after CSIG silencing. (A) Schematic presentation of the full-length PTEN cDNA and various transcripts derived from the 5Ј UTR, CR, and 3Ј UTR used in this study. (B) Whole-cell lysates (100 g) were prepared from HEK 293 cells, and endogenous target transcripts were detected by RT-PCR assay of the corresponding IP materials; PCR products corresponding to PTEN mRNA were visualized on agarose gel. The PCR product of GAPDH served as a negative Ctrl. (C) Results of a pulldown assay using biotinylated fragments to detect bound CSIG by Western blotting. A 10-g portion of whole-cell lysates (Lys.) and binding of HuR (positive Ctrl) and ␣-tubulin (negative Ctrl) to PTEN mRNA were included. (D) A polysomal fraction from HEK 293 cell lysates was prepared and subjected to Western blot analysis to evaluate the presence of CSIG. (E) pGL3, pGL3-5Ј UTR, pGL3-CR, and pGL3-3Ј UTR-2 plasmid (0.1 g/ml) were transiently transfected into HEK 293 cells along with the pRL-CMV reporter (5 ng/ml) as a Ctrl. Twenty-four hours later, transfected cells were cotransfected either with CSIG siRNA to silence CSIG or with a Ctrl siRNA for 48 h; firefly luciferase activities were determined and normalized against Renilla luciferase activity. Values represent means Ϯ standard errors of the means (SEM) of the results for five independent experiments. (F) Left panel: pGL3-5Ј UTR (0.1 g/ml), pRL-CMV (5 ng/ml) plasmids, and a different dose of pcDNA-5Ј UTR [0 g/ml (Ϫ), 2 g/ml (ϩ), 4 g/ml (ϩϩ), or 6 g/ml (ϩϩϩ)] were transiently cotransfected into HEK 293 cells for 48 h. Right panel: pGL3-5Ј UTR (0.1 g/ml), pRL-CMV (5 ng/ml) plasmids, and pcDNA vectors expressing PTEN 5Ј UTR fragments A, B, C, or D (6 g/ml) were transiently cotransfected into HEK 293 cells for 48 h; firefly luciferase activities then were determined and normalized against Renilla luciferase activity. Values represent means Ϯ SEMs of the results for five independent experiments.
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Ctrl cells but failed to increase p27
Kip1 expression in PTENsilenced cells. Similar to our results in Fig. 6B and D, silencing of CSIG resulted in reduced proliferation rates and increased SA-␤-gal activity compared with the Ctrl siRNA-expressing cells ( Fig.   7B and C) . However, 2BS cells cotransfected either with Ctrl siRNA plus PTEN siRNA or with CSIG siRNA plus PTEN siRNA displayed higher cell proliferation rates than those observed in Ctrl siRNA-expressing cells (Fig. 7B) . More impor- tantly, knockdown of CSIG failed to elevate SA-␤-gal activity in PTEN-silenced 2BS cells (Fig. 7C) . Therefore, PTEN is not only required for CSIG to regulate p27 Kip1 and cell proliferations but is essential for CSIG's role in regulating replicative senescence.
DISCUSSION
The present study stemmed from our previous findings using suppressive subtractive hybridization, whereby the CSIG transcript was dramatically higher in young 2BS cells than in senescent cells. Here, we set out to test whether CSIG is important for the progression to senescence. We originally demonstrated an age-dependent reduction of CSIG expression in 2BS fibroblasts, a model cell line that is routinely used for the study of replicative senescence (11, 20, 33, 36, (39) (40) (Fig. 1D) . We further demonstrate that overexpression of CSIG in 2BS cells promotes cell growth, increases the S phase compartment, and delays the progression to senescence. In contrast, silencing of CSIG led to slow cell growth, decreased the S and G 2 /M compartments, and accelerated cellular senescence (Fig. 6) . Together, this evidence indicates that CSIG is capable of modulating the process of replicative senescence. While elevation of both p16
INK4a and p21 Cip1 are key hallmarks of entry into cell senescence, neither of them appear to mediate the effect of CSIG on senescence, as ectopic intervention to either elevate or reduce CSIG levels failed to influence their levels. Instead, elevating CSIG expression negatively influences PTEN and p27 Kip1 ( Fig. 2A and B) , suggesting that these proteins are downstream effectors of CSIG's influence on cell proliferation and senescence. It is likely that CSIG is also involved in the regulation of in vivo aging and that additional targets of CSIG may also participate in the implementation of cell proliferation and senescence. In this regard, studies to assess the CSIG levels in young and aged mouse tissues, to develop a knockout system, and to screen more targets of CSIG during cellular and tissue aging are under way in our laboratory. The results of these studies will hopefully provide a more complete understanding of the role of CSIG and its mechanisms of action.
The CDK inhibitor p27 Kip1 is important for G 0 /G 1 arrest during cell aging (1, 4) . Degradation of p27
Kip1 is a critical event for the G 1 /S transition and occurs through ubiquitination by SCF Skp2 and subsequent degradation by the 26S proteasome (27) . Regulation of p27 Kip1 by PTEN has been reported broadly. For example, ectopic expression of PTEN in human glioblastoma cells led to accumulation of p27 Kip1 (19, 29) , while PTEN deficiency in mouse embryonic stem cells led to decreased p27 Kip1 levels (32). Emerging evidence suggests that PTEN inhibits the ubiquitindependent degradation of p27 Kip1 , elevates p27
Kip1 levels, which in turn, negatively regulates the G 1 /S cell cycle transition (9, 21, 23, 32) . The PTEN/p27
Kip1 pathway is important for controlling the replicative senescence and life span of normal human fibroblasts (1, 4, 28) . Although both PTEN and p27
Kip1 levels are influenced by CSIG, our findings clearly indicate that PTEN, but not p27 Kip1 , is the direct target of CSIG. In other words, PTEN is required for the regulation of p27
Kip1 by CSIG. We arrive at this conclusion from the following two observations: (i) ectopic intervention to either elevate or reduce CSIG expression failed to significantly change p27
Kip1 expression in PTEN-deficient U87 cells (Fig. 3B) , and (ii) silencing of PTEN in HEK 293 cells by an siRNA approach also dramatically diminished the effect of ectopic intervention to either elevate or reduce CSIG levels on p27
Kip1 expression (Fig. 3C) . Not surprisingly, the PTEN/p27 pathway acts as a major mediator for CSIG-regulated cell proliferation and senescence, as knockdown of CSIG failed to affect cell cycle progression and proliferation ( Fig. 3D and E and 7B) as well as the senescent phenotype (Fig. 7C ) in PTEN-deficient or -silenced cells. According to the model that emerges from this study, we propose that high CSIG expression in young cells contributes to the low levels of PTEN and keeps cells from aging, as characterized by high proliferation state and low SA-␤-gal activity. In accordance with the age-dependent decrease of CSIG, expression levels of PTEN increased with replicative senescence (Fig. 4F, left panel) , which in turn leads to increased levels of p27 Kip1 and its downstream effectors. Interestingly, the robust increase of PTEN in senescent cells was not accompanied by a concomitant elevation in PTEN mRNA abundance (Fig. 4F, right panel) , suggesting that a posttranscriptional mechanism is involved in the regulation of PTEN by CSIG. Accordingly, either overexpression or knockdown of CSIG failed to affect PTEN mRNA levels ( Fig. 4C and D) . Therefore, CSIG-regulated expression of PTEN must be achieved by either translational or posttranslational events. Indeed, newly synthesized PTEN is much more abundant after silencing of CSIG (Fig. 4E) , indicating that enhanced PTEN translation is a critical mechanism leading to PTEN accumulation. Although ubiquitin-dependent proteasome degradation has been described as an important mechanism for the regulation of PTEN (35, 37) , CSIG is unlikely to regulate PTEN through this mechanism because silencing of CSIG expression by RNA interference in 2BS cells did not affect the PTEN proteasome turnover rate (our unpublished data). It is likely that CSIG downregulates PTEN by inhibiting its translation during replicative senescence. Consistently, our results showed that CSIG predominantly localized in the nucleolus (Fig. 1C) , the major site for synthesizing and assembling ribosomal subunits. This result was recently confirmed by another group showing that CSIG/RSL1D1 colocalizes with nucleostemin in the nucleolus (25) .
The structural feature of CSIG with the N-terminal ribosomal L1p/L10e consensus sequence (residues 30 to 260) and the predominant nucleolus localization suggest that CSIG acts as a ribosome-associated protein. This is supported by the evidence that CSIG is present in the cell's polysomal fraction (Fig. 5D ) and formed a complex with PTEN 5Ј UTR (Fig. 5B  and C) . The PTEN 5Ј UTR confers higher luciferase activity to PTEN 5Ј UTR-luciferase chimeric mRNA. More importantly, the PTEN 5Ј UTR-related luciferase activity increased significantly after CSIG silencing (Fig. 5E) . Therefore, interaction of CSIG with PTEN 5Ј UTR may be critical for the role of CSIG in PTEN translational regulation. The CSIG response element in PTEN 5Ј UTR appears to localize between positions 700 and 830 because the luciferase activity of PGL3-5ЈUTR could be competed by coexpression of PTEN 5Ј UTR fragments A, B, and C, but not D (Fig. 5F, right panel) . However, in vitro RNA-protein binding assays using in vitro-expressed GST-CSIG recombinant protein and 32 P-labeled PTEN 5Ј UTR did not show direct binding between CSIG and PTEN 5Ј UTR (our unpublished results), suggesting that CSIG may not act as an RNA binding protein. It remains possible that posttranslational modifications are absent in the purified, bacterially expressed CSIG protein in order for CSIG to bind a target transcript; however, we favor the view that CSIG may instead interact either with bona fide RNA binding proteins implicated in regulating translation or with components of PTEN translation complex. It will be of great interest to investigate whether CSIG is a common regulator of translation and how CSIG selectively exerts its effect on certain targets, such as PTEN, during cellular senescence. In our ongoing studies, we are screening targets of CSIG other than PTEN by using cDNA/protein arrays and investigating whether CSIG acts as a ribosomal component or as a cofactor of translation. The results of this work will likely enhance our understanding of CSIG function during the process of replicative senescence.
